WuXi's STA to build massive manufacturing facility in Delaware, adding 500 jobs

URLhttps://www.fiercepharma.com/manufacturing/kind-a-
SourceFierce Pharma
Date Published06/21/2021
Author NameKevin Dunleavy
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name STA Pharmaceutical
Parent companyWuxi AppTech
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Total number of jobs (added or to be added):479
Year reshoring announced:2022
Year reshoring implemented or to be implemented:2024
Domestically, the work will be done:In-house
Capital investment ($):510
Country(ies) from which reshored:China
City reshored to:Middletown
State(s) reshored to:DE
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredpharmaceuticals
What domestic positive factors made reshoring more attractive?Government Incentives
Government Incentive dollar amount:19,000,000
Find Reshoring Articles